Recommendations for the Management of Patients with Unruptured Intracranial Aneurysms
Stroke 31:2742-2750, Bederson,J.B.,et al, 2000
Effect on Migraine of Closure of Cardiac Right-to-Left Shunts to Prevent Reucrrence of Decompression Illness or Stroke or for Haemodynamic Reasons
Lancet 356:1648-1651, Wilmshurst,P.T.,et al, 2000
Primary Stenting for High-Grade Basilar Artery Stenosis
AJNR 21:1744-1749, Phatouros,C.C.,et al, 2000
The Association Between the Diameter of a Patent Foramen Ovale and the Risk of Embolic Cerebrovascular Events
Am J Med 109:456-462,506, Schuchlenz,H.W.,et al, 2000
Interatrial Septal Abnormalities and Stroke
Neurol 55:1172-1179, Overell,J.R.,et al, 2000
Pulmonary Arteriovenous Malformations
Neurol 55:959-964, Moussouttas,M.,et al, 2000
Morphological and Functional Characteristics of Patent Foramen Ovale and Their Embolic Implications
Stroke 31:2407-2413, De Castro,S.,et al, 2000
Cost-Effectiveness of New Antiplatelet Regimens Used as Secondary Prevention of Stroke or Transient Ischemic Attack
Arch Int Med 160:2773-2778, Sarasin,F.P.,et al, 2000
Cerebral Venous Thrombosis: Anticoagulants or Thrombolyic Therapy?
JNNP 69:427-430, Benamer,H.T.S. & Bone,I., 2000
Neurologic Manifestations of Infective Endocarditis
Arch Int Med 160:2781-2787, Heiro,M.,et al, 2000
Anticoagulant Patient Information Material Is Written at High Readability Levels
Stroke 31:2966-2970, Estrada,C.A.,et al, 2000
Safety of Discontinuation of Anticoagulation in Patients with Intracranial Hemorrhage at High Thromboembolic Risk
Arch Neurol 57:1710-1713,1682, Phan,T.G.,et al, 2000
Subarachnoid Haemorrhage Treated with Anticoagulants
Lancet 356:1818, Ciccone,A.,et al, 2000
Prevention of Ischaemic Stroke
BMJ 321:1455-1459, Gubitz,G. & Sandercock,P., 2000
Arteriovenous Bubbles Following Cold Water Sport Dives: Relation to Right-to-left Shunting
Neurol 55:1741-1743, Gerriets,T.,et al, 2000
De Novo Mutation in the Notch3 Gene Causing CADASIL
Ann Neurol 47:388-391, Joutel,A.,et al, 2000
Selective Infusion of Urokinase and Thrombectomy in the Treatment of Acute Cerebral Sinus Thrombosis
AJNR 21:143-145, Novak,Z.,et al, 2000
Ischemia After Carotid Endarterectomy:Comparison between Transcranial Doppler Sonography and Diffusion-Weighted MR Imaging
AJNR 21:47-54,41, Muller,M.,et al, 2000
AGGRENOX: A Combination of Antiplatelet Drugs for Stroke Prevention
The Medical Letter 442:11-12, , 2000
Incidence of Postangiographic Abnormalities Revealed by Diffusion-Weighted MR Imaging
AJNR 21:55-59, Britt,P.M.,et al, 2000
Rate of Stroke Recurrence in Patients with Primary Intracerebral Hemorrhage
Stroke 31:123-127, Hill,M.D.,et al, 2000
Effect of Endovascular Services and Hospital Volume on Cerebral Aneurysm Treatment Outcomes
Stroke 31:111-117, Johnston,S.C., 2000
Multiple Acute Stroke Syndrome, Marker of Embolic Disease?
Neurol 54:674-678, Baird,A.E.,et al, 2000
Plaque Morphology Correlates with Cerebrovascular Symptoms in Patients with Complex Aortic Arch Plaque
Arch Neurol 57:81-84, Weinberger,J.,et al, 2000
Intraspinal Hemorrhage Complicating Oral Anticoagulant Therapy, An Unusual Case of Cervical Hematomyelia and a Review of the Literature
Arch Int Med 160:237-240, Pullarkat,V.A.,et al, 2000
Endovascular Treatment of Ruptured Posterior Circulation Cerebral Aneurysms, Clinical and Angiographic Outcomes
Stroke 31:100-110, Lempert,T.E.,et al, 2000
Transient Ischaemic Attack in a Young Woman
Lancet 355:622, Lee,P. & Tse, H., 2000
Causes and Severity of Ischemic Stroke in Patients With Internal Carotid Artery Stenosis
JAMA 283:1429-1436, 1479, Barnett, H.J.M.,et al, 2000
Aspirin for the Primary Prevention of Stroke and Other Major Vascular Events
ArchNeurol 57:326-332,306, Hart,R.G.,et al, 2000
Early Lacunar Strokes Complicating Polyarteritis Nodosa
Neurol 54:883-889, Reichhart,M.D.,et al, 2000
Cerebral Sinus Thrombosis Diagnosed by MRI and MR Venography in Cancer Patients
Neurol 54:1222-1226, Raizer,J.J.&DeAngelis,L.M., 2000
Decision Analysis and Guidelines for Anticoagulant Therapy to Prevent Stroke in Patients with Atrial Fibrillation
Lancet 355:956-962, Thomson,R.,et al, 2000
Risk Factors for Lacunar Stroke:A Case-Control Transesophageal Echocardiographic Study
Neurol 54:1385-1387, Kazui,S.,et al, 2000
Neurological Manifestations of Dengue Infection
Lancet 355:1053-1059, Solomon,T.,et al, 2000
Aspirin-Associated Intracerebral Hemorrhage
Neurol 54:2298-2301, Wong,K.S.,et al, 2000
Update on Antiplatelet Therapy for Stroke Prevention
Arch Int Med 160:1579-1582, Sacco,R.L.& Elkind,M.S., 2000
Anticoagulation for Chronic Atrial Fibrillation
JAMA 283:2901-2903, Stern,S.,et al, 2000
Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel
NEJM 342:1773-1777,1824, Bennett,C.L.,et al, 2000
Reduced Prevalence of AD in Users of NSAIDs and H2 Receptor Antagonists
Neurol 54:2066-2071, Anthony,J.C.,et al, 2000
Indications for Early Aspirin Use in Acute Ischemic Stroke
Stroke 31:1240-1249, Chen,Z.,et al, 2000
The Causes and Risk of Stroke in Patients with Asymptomatic Internal-Carotid-Artery Stenosis
NEJM 342:1693-16700, Inzitari,D.,et al, 2000
Endovascular Treatment of Dural Sinus Thrombosis With Rheolytic Thrombectomy and Intra-Arterial Thrombolysis
Stroke 31:1420-1425, Chow,K.,et al, 2000
Stroke Prevention
Neurol 54:1899-1906, Holloway,R.G.,et al, 2000
Multifocal Brain MRI Hypointensities Secondary to Cardiac Catheterization
Neurol 54:2023-2024, Jassal,D.S.,et al, 2000
Prospective Cohort Study to Determine if Trial Efficacy of Anticoagulation for Stroke Prevention in Atrial Fibrillation Translates Into Clinical Effectiveness
BMJ 320 :1236-1239,1219, Kalra,L.,et al, 2000
Diffusion- and Perfusion-Weighted MRI Patterns in Borderzone Infarcts
Stroke 31:1090-1096, Chaves,C.J.,et al, 2000
Clinical Characteristics of Pathologically Proved Cholesterol Emboli to the Brain
Neurol 54:1681-1683, Ezzeddine,M.A.,et al, 2000
Motor Strokes Sparing the Leg
Arch Neurol 57:513-518, de Freitas,G.R.,et al, 2000
Low Molecular-Weight Heparin Versus Aspirin in Patients With Acute Ischaemic Stroke and Atrial Fibrillation: A Double-Blind Randomised Study
Lancet 355:1205-1210, Berge,E.,et al, 2000
Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Stroke 31:817-821, Yamaguchi,T., 2000